172 related articles for article (PubMed ID: 16194453)
1. Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology.
Tempero MA; Behrman S; Ben-Josef E; Benson AB; Cameron JL; Casper ES; Hoffman JP; Karl RC; Kim P; Koh WJ; Kuvshinoff BW; Melvin WS; Muscarella P; Sasson AR; Shibata S; Shrieve DC; Talamonti MS; Tyler DS; Vickers SM; Warren RS; Willett C; Wolff RA;
J Natl Compr Canc Netw; 2005 Sep; 3(5):598-626. PubMed ID: 16194453
[No Abstract] [Full Text] [Related]
2. [Combined locoregional therapeutic strategy in locally advanced cancers of the pancreas].
Manivit P; Polo R
Ann Chir; 1998; 52(1):100. PubMed ID: 9752423
[No Abstract] [Full Text] [Related]
3. Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study.
André T; Balosso J; Louvet C; Hannoun L; Houry S; Huguier M; Colonna M; Lotz JP; De Gramont A; Bellaïche A; Parc R; Touboul E; Izrael V
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):903-11. PubMed ID: 10705012
[TBL] [Abstract][Full Text] [Related]
4. [Gastric neoplasm, multidisciplinary management].
Bohanes Pi; Roth AD; Huber O; Aapro MS; Plan PA
Rev Med Suisse; 2009 Aug; 5(212):1569-75. PubMed ID: 19728453
[No Abstract] [Full Text] [Related]
5. [Locally advanced adenocarcinoma of the pancreas: current therapeutic modalities].
Lombard-Bohas C; Mornex F; Saurin JC
Cancer Radiother; 1997; 1(5):547-54. PubMed ID: 9587388
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant therapy for resectable pancreatic cancer.
Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy for pancreatic cancer: current status and future directions.
Xiong HQ; Abbruzzese JL
Surg Oncol Clin N Am; 2004 Oct; 13(4):737-49, xi. PubMed ID: 15350945
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma.
Saidi RF; Jacobs MJ
Ann Surg; 2009 May; 249(5):865; author reply 865-6. PubMed ID: 19387303
[No Abstract] [Full Text] [Related]
9. The promise of modern radiotherapy in resected pancreatic adenocarcinoma: a response to Bekaii-Saab et al.
Narang AK; Herman JM
Ann Surg Oncol; 2014 Apr; 21(4):1064-6. PubMed ID: 24522986
[No Abstract] [Full Text] [Related]
10. [Adenocarcinoma of the pancreas. Therapeutic strategies].
André T; Balosso J; Louvet C; Houry S; Vaillant JC; Touboul E; Lotz JP; de Gramont A; Izrael V
Presse Med; 1998 Mar; 27(11):539-45. PubMed ID: 9767970
[TBL] [Abstract][Full Text] [Related]
11. [Combination therapy in oncology (multimodal treatment) in pancreatic tumors].
Ihse I; Andersson R; Axelson J; Hansson L
Chirurg; 1998 Apr; 69(4):366-70. PubMed ID: 9612618
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic adenocarcinoma.
Eskander MF; Bliss LA; Tseng JF
Curr Probl Surg; 2016 Mar; 53(3):107-54. PubMed ID: 26923296
[No Abstract] [Full Text] [Related]
13. Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy.
Evans DB; Erickson BA; Ritch P
Ann Surg Oncol; 2010 Nov; 17(11):2803-5. PubMed ID: 20737218
[No Abstract] [Full Text] [Related]
14. [Recommendations for the diagnosis, staging and treatment of pre-malignant lesions and pancreatic adenocarcinoma].
Martin-Richard M; Ginès A; Ayuso JR; Sabater L; Fabregat J; Mendez R; Fernández-Esparrach G; Molero X; Vaquero EC; Cuatrecasas M; Ferrández A; Maurel J;
Med Clin (Barc); 2016 Nov; 147(10):465.e1-465.e8. PubMed ID: 27726847
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.
Tempero MA; Arnoletti JP; Behrman SW; Ben-Josef E; Benson AB; Casper ES; Cohen SJ; Czito B; Ellenhorn JD; Hawkins WG; Herman J; Hoffman JP; Ko A; Komanduri S; Koong A; Ma WW; Malafa MP; Merchant NB; Mulvihill SJ; Muscarella P; Nakakura EK; Obando J; Pitman MB; Sasson AR; Tally A; Thayer SP; Whiting S; Wolff RA; Wolpin BM; Freedman-Cass DA; Shead DA;
J Natl Compr Canc Netw; 2012 Jun; 10(6):703-13. PubMed ID: 22679115
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy of pancreatic cancer.
Hilbig A; Oettle H
Expert Rev Anticancer Ther; 2010 Apr; 10(4):485-91. PubMed ID: 20397913
[TBL] [Abstract][Full Text] [Related]
17. Current standards and new innovative approaches for treatment of pancreatic cancer.
Conroy T; Bachet JB; Ayav A; Huguet F; Lambert A; Caramella C; Maréchal R; Van Laethem JL; Ducreux M
Eur J Cancer; 2016 Apr; 57():10-22. PubMed ID: 26851397
[TBL] [Abstract][Full Text] [Related]
18. The Virginia Mason approach to localized pancreatic cancer.
Picozzi VJ; Traverso LW
Surg Oncol Clin N Am; 2004 Oct; 13(4):663-74, ix. PubMed ID: 15350940
[TBL] [Abstract][Full Text] [Related]
19. Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
Nukui Y; Picozzi VJ; Traverso LW
Am J Surg; 2000 May; 179(5):367-71. PubMed ID: 10930481
[TBL] [Abstract][Full Text] [Related]
20. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
Labori KJ; Katz MH; Tzeng CW; Bjørnbeth BA; Cvancarova M; Edwin B; Kure EH; Eide TJ; Dueland S; Buanes T; Gladhaug IP
Acta Oncol; 2016; 55(3):265-77. PubMed ID: 26213211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
